RxE2 is fundamentally revolutionizing clinical research by utilizing, for the first time ever, community pharmacy as clinical sites. This model addresses the core industry struggle where 80% of traditional clinical trials finish late, often costing hundreds of millions of dollars. RxE2 powers efficient community-based clinical trials by connecting sponsors with a network of thousands of pharmacies for direct patient access, decentralized trial visits, and recruitment. This efficiency relies on leveraging the critical deep trust patients have in their local pharmacists.